Molina Healthcare (MOH) vs Progyny (PGNY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Progyny (PGNY) has outperformed Molina Healthcare (MOH) over the past year, gaining 37.8% versus a loss of 4.2%. Over five years, MOH leads with a -30.4% price change compared with -50.8% for PGNY. Molina Healthcare is the larger company by market cap ($10.17 billion vs $2.11 billion), about 4.8 times the size.
On valuation, Progyny trades at a lower forward P/E (11.9x vs 20.0x for Molina Healthcare).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MOH | PGNY |
|---|---|---|
| Share price | $194.82 | $27.55 |
| Market cap | $10.17B | $2.11B |
| 1-day change | -0.18% | +6.33% |
| YTD return | +12.26% | +7.28% |
| 1-year return | -4.15% | +37.75% |
| 5-year return | -30.44% | -50.79% |
| P/E ratio (TTM) | — | 29.95 |
| Forward P/E | 19.99 | 11.88 |
| EPS (TTM) | $0.09 | $0.92 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $45.43B | — |
| Revenue growth (YoY) | +11.75% | — |
| Net income (latest FY) | $472.00M | — |
| Gross margin | 13.07% | — |
| Operating margin | 1.72% | — |
| Net margin | 1.04% | — |
| 52-week high | $244.89 | $33.07 |
| 52-week low | $121.06 | $16.10 |
| Distance from 52-week high | -20.45% | -16.68% |
| Analyst consensus | hold | none |
| Avg. price target upside | +7.34% | +24.94% |
| Average volume | 913.17K | 1.13M |
| Shares outstanding | 52.20M | 76.73M |
| Employees | 19,000 | 835 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Misc Health and Biotechnology Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Molina Healthcare is about 4.8 times larger than Progyny by market value ($10.17B vs $2.11B).
- PGNY has outperformed MOH by 41.9 percentage points over the past year.
About Molina Healthcare
MOH stock →Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces in the United States.
Health Care · Medical Specialities · 19,000 employees
About Progyny
PGNY stock →Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists.
Health Care · Misc Health and Biotechnology Services · 835 employees
MOH vs PGNY FAQ
Which is bigger, Molina Healthcare or Progyny?
Molina Healthcare (MOH) is larger, with a market capitalization of $10.17B compared with $2.11B for Progyny (PGNY).
Which stock has performed better over the past year, MOH or PGNY?
PGNY returned +37.75% over the past 12 months, compared with -4.15% for MOH (price return, excluding dividends). Past performance does not predict future results.
Are Molina Healthcare and Progyny in the same industry?
Both are in the Health Care sector, but in different industries: Medical Specialities for Molina Healthcare and Misc Health and Biotechnology Services for Progyny.